Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Dec
21
2021
More Whiplash — DC Brings Back Mask Mandate and Encourages Vaccine Mandates Proskauer Rose LLP
Dec
21
2021
District Court Rejects Purdue Pharma’s Chapter 11 Plan Over Non-Consensual Releases Provided to Sackler Family Squire Patton Boggs (US) LLP
Dec
17
2021
EC Denies Authorization of Titanium Dioxide (E171) as a Feed Additive for All Animal Species, Requires Products Be Withdrawn from the Market in 2022 Bergeson & Campbell, P.C.
Dec
17
2021
President Biden Signs Executive Order to Address Drug Trafficking Cadwalader, Wickersham & Taft LLP
Dec
16
2021
New Ruling Throws Healthcare Facility Vaccine Mandates Into State Versus State Barnes & Thornburg LLP
Dec
16
2021
3D Printing Medical Devices at the Point of Care — FDA Invites Feedback Foley & Lardner LLP
Dec
16
2021
OEHHA Modifies Prop 65 Short-Form Warning Proposal Keller and Heckman LLP
Dec
16
2021
EU Proposed Regulation on Deforestation-Free Products: Impact on Food Businesses Greenberg Traurig, LLP
Dec
16
2021
Post-AIA Patents Are Not Shielded from Interferences McDermott Will & Emery
Dec
16
2021
New York City Issues Order, Guidance on COVID-19 Vaccine Requirement for Private Sector Businesses Jackson Lewis P.C.
Dec
16
2021
CMS Issues Guidance on COVID-19 Testing in the Workplace Epstein Becker & Green, P.C.
Dec
16
2021
Rounding Error: Intrinsic Evidence Informs Plain and Ordinary Meaning McDermott Will & Emery
Dec
16
2021
Further Guidance on Overseas Food Facility Registration Published by China Customs Authority Keller and Heckman LLP
Dec
16
2021
Obvious to Try Requires Reasonable Expectation of Success Tethered to Claimed Invention McDermott Will & Emery
Dec
16
2021
Making a List, Checking It Twice: Year-End Guidance on Drug Cost Reporting Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Dec
16
2021
New Jersey State Health Benefits Program: Multimillion Dollar Cash Cow for Pharma Fraudsters Tycko & Zavareei LLP
Dec
15
2021
Red Light – Green Light: CMS Vaccination Mandate is On Again in 26 States? Foley & Lardner LLP
Dec
15
2021
When Nondisclosure Agreements and Pharmaceutical Trade Secrets Intersect Proskauer Rose LLP
Dec
15
2021
New Bill Aims to Clarify Confusing Food Date Labels Keller and Heckman LLP
Dec
14
2021
Seed to Sale: Keeping Out of the Weeds in Corporate and Financial Transactions Womble Bond Dickinson (US) LLP
Dec
14
2021
FSIS Retail Listeria monocytogenes (Lm) Pilot Project Update Keller and Heckman LLP
Dec
14
2021
Court Cuts Short Challenge to Zicam’s “Clinically Proven to Shorten Colds” Claims Proskauer Rose LLP
Dec
14
2021
CMS Issues Memorandum Stating It Will Not Enforce Its COVID-19 Vaccine Mandate While There are Court-Ordered Injunctions in Place Robinson & Cole LLP
Dec
13
2021
Debate Continues Around Scope of Practice Expansion for APPs Sheppard, Mullin, Richter & Hampton LLP
Dec
13
2021
Health Law Policy Heading Into 2022 At The ABA Health Law Summit Sheppard, Mullin, Richter & Hampton LLP
Dec
13
2021
Litigation to Proceed Over Barilla Pasta Sauce with ‘No Preservatives’ Claim Keller and Heckman LLP
Dec
11
2021
Philadelphia Ban on Pre-Hire Marijuana Testing Takes Effect on January 1, 2022 Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Dec
10
2021
FDA Issues Draft Guidance On the Use and Curation of Real-World Data in Registries McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins